Bypassing Peer Review

Eugene Russo addresses the increasing problem of researchers bypassing the peer review process for publication in the popular media.1 There are many reasons for this, and they stem from the incompatibility of present-day peer review practices with the information age. This letter addresses peer review pros and cons (mainly for R&D) and presents an approach to overcome some of the more egregious roadblocks. There are many reasons for performing peer review. Probably the main peer review

Written byRonald Kostoff
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Eugene Russo addresses the increasing problem of researchers bypassing the peer review process for publication in the popular media.1 There are many reasons for this, and they stem from the incompatibility of present-day peer review practices with the information age. This letter addresses peer review pros and cons (mainly for R&D) and presents an approach to overcome some of the more egregious roadblocks.

There are many reasons for performing peer review. Probably the main peer review benefit today is the filtering by credentialed experts of enormous amounts of data of widely varying quality. This allows the researcher to focus his/ her efforts on the highest-quality portion of that data, and not waste time on unsubstantiated data. It is the foundational requirement for high-quality text mining.

There are many reasons to avoid peer review, including time delay, theft of ideas, leaking of ideas, incompetent reviewers, poor research, and financial gain by ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies